Symbols

ARCT

Arcturus Therapeutics·NASDAQ

--(--)

ARCT Profile

Arcturus Therapeutics Holdings Inc.

A company that developing lipid nanoparticle siRNA drug delivery systems for the orphan disease market

Industry

Pharmaceutical

Established Date

02/07/2008

Listing Date

05/22/2013

Exchange

NASDAQ Stock Exchange

Full-time Employees

106

Fiscal Year Ends

12-31

Website

www.arcturusrx.com

Security Type

Common stock

Office address

10285 Science Center Drive, San Diego, California 92121

Business

Introduction

Arcturus Therapeutics Holdings Inc., incorporated and commenced operations in Israel on February 7, 2008, and re-incorporated in Delaware. The company is a messenger ribonucleic acid drug company focused on developing therapies for rare diseases of the liver and respiratory tract. Its platform technologies include a proprietary self-replicating mRNA and lipid nanoparticle delivery system, supporting a pipeline of drug candidates for diseases such as ornithine carbamyltransferase deficiency and cystic fibrosis, and a co-developed COVID - 19 vaccine.